Current Issue

Dec 2024View Current Issue

Ovarian cancer is the most common cause of lethality among women with gynecological cancers. In Europe, it ranks fifth in frequency in women after malignancies of the mammary gland, colon, lung and uterine body. Generally, it is diagnosed at an advanced stage (III-IV) due to the non-specificity of symptoms in the early stage and the lack of effective screening methods. The majority of patients with advanced epithelial ovarian cancer are indicated either for neoadjuvant chemotherapy followed by optimal cytoreduction or optimal cyto-reduction followed by adjuvant chemotherapy. This ....[more]

Evaluation of Sentinel Lymph Node Biopsy in Papillary Carcinoma of Thyroid During Total Thyroidectomy
Ahmed Ezzat Abd El-Rahiem Mohamed, Wafi Fouad Salib, Hesham Omran, George Magdy Halim Khella
ORIGINAL PAPER, Dec 2024
Article DOI: 10.21614/sgo-722
Read article

Background: Lymph node metastases are very common in papillary thyroid carcinoma affecting the survival of patients. The appropriate management of cervical lymph nodes is very important. Therefore, this study evaluated the utility of sentinel lymph node biopsy (SLNB) using methylene blue in the central neck compartment. Objective: The aim of this study is to investigate the possibility of using the SLNB to predict micro metastasis in papillary carcinoma of thyroid to avoid the unnecessary central lymph node dissection.

Patients and Methods: This pro....[more]

Risk Factors and Morbidity Pattern of Patients with Peptic Ulcer Undergoing Endoscopic Examination
Rifqa Saad Abdulwahhab AlSalman, Mohamed Hesham Shawi Alshawi, Alaa Salman Dawood Alahmed, Omran Habib, Abbas Ali Mansour, Ahmed Salih Alshewered
ORIGINAL PAPER, Dec 2024
Article DOI: 10.21614/sgo-712
Read article

Background: the prevalence of peptic ulcer (PU) is declining in Western because of widespread use of Helicobacter pylori (H. pylori) eradication drugs, however, it still high in developing regions. The study aimed to explore certain aspects of cases with PU and to identify the predictors of PU related to risk factors.

Material and Methods: the study was conducted at the endoscopic unit at Al-Sadr Teaching Hospital. A cross-sectional study involving 152 cases who underwent endoscopic examination by specialist doctors. All patients were inte....[more]

Urine Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury Following Liver Transplantation
Abdel-Naser Abdel-Atty Gadallah, Amr Ragab Shalaby, Hanan Mosaad Bedair, Asmaa Yehia Ahmed Hikal, Hany Abd Elaziz Abd Elbary
ORIGINAL PAPER, Dec 2024
Article DOI: 10.21614/sgo-715
Read article

Background: acute kidney injury (AKI) is a prevalent complication that occurs following liver transplantation (LT). Aim: to evaluate the value of urinary neutrophil gelatinase-associated lipocalin (UNGAL) in detecting AKI following LT.

Material and Methods: the present study adopted a randomized, prospective, double-

blinded design. The trial was carried out on 38 patients who underwent evaluation for AKI

following LT at Menoufia University’s National Liver Institute. The study took place between January 2023 and June....[more]

Therapeutic Impact of RAS Testing on Survival Outcomes in Moroccan Metastatic Colorectal Cancer Patients
Sofia Fathi, Oussama Aazzane, Selma Guedanoui, Nezha Tawfiq, Souha Sahraoui, Fadila Guessous, Mehdi Karkouri
ORIGINAL PAPER, Dec 2024
Article DOI: 10.21614/sgo-718
Read article

Introduction: RAS mutations, particularly KRAS and NRAS mutations, are frequent drivers of metastatic colorectal cancer (mCRC) and confer resistance to anti-EGFR targeted therapy. This study investigated the impact of RAS molecular testing on treatment patterns and survival outcomes in Moroccan mCRC patients.

Material and Methods: A retrospective study was conducted among patients diagnosed mCRC and treated at Ibn Rochd University Hospital, Casablanca, Morocco, between 2019 and 2023. All patients received first-line chemotherapy followed b....[more]

Search The Journal

Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/